Drug class
Low-molecular-weight heparin (LMWH); antithrombin-dependent anticoagulant
Mechanism of action
Binds antithrombin and accelerates inhibition of coagulation factor Xa, with less activity against thrombin (factor IIa) than unfractionated heparin, reducing fibrin formation and thrombus propagation.
General use cases
- Prevention of venous thromboembolism in surgical and selected medical patients at risk, and treatment of thromboembolic conditions in countries where certoparin is authorised; product-specific dosing and availability apply
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
